Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.

about

Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.

Item

http://www.wikidata.org/entity/Q47139108

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Characterization of rubella-sp ...... roteome microarray technology.

@en

Characterization of rubella-sp ...... roteome microarray technology.

@nl

type

Item

label

Characterization of rubella-sp ...... roteome microarray technology.

@en

Characterization of rubella-sp ...... roteome microarray technology.

@nl

prefLabel

Characterization of rubella-sp ...... roteome microarray technology.

@en

Characterization of rubella-sp ...... roteome microarray technology.

@nl

P1476

Characterization of rubella-sp ...... roteome microarray technology.

@en

P2093

Diane E Grill

http://www.w3.org/2001/XMLSchema#string

Michael J Gibson

http://www.w3.org/2001/XMLSchema#string

Nathaniel D Warner

http://www.w3.org/2001/XMLSchema#string

Richard B Kennedy

http://www.w3.org/2001/XMLSchema#string

P2860

High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titers

Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein

Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc Receptor-Dependent and -Independent Mechanisms

VERIFICATION OF FORECASTS EXPRESSED IN TERMS OF PROBABILITY

Three cases of congenital rubella syndrome in the postelimination era--Maryland, Alabama, and Illinois, 2012.

Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination.

Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity

Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees

Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment

P304

e0188149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0188149

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gregory Poland

Inna G Ovsyannikova

Iana H Haralambieva

P577

2017-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29145521

http://www.w3.org/2001/XMLSchema#string

P921

rubella

P932

5690594

http://www.w3.org/2001/XMLSchema#string